Fluorene Myristate

Fluorene myristate is sold in the research-chemical and nootropic market with almost no accompanying scientific documentation. The name implies an ester formed between myristic acid (a 14-carbon fatty acid) and a fluorene-derived alcohol, most plausibly 9-fluorenol (also called fluorenol or hydrafinil). Attaching a long fatty-acid chain is a common way to make a molecule more lipophilic and to slow its release or absorption, which is the likely rationale if this is indeed a fluorenol prodrug.

The better-characterized parent, 9-fluorenol, is described in the wider literature as a weak inhibitor of the dopamine transporter and a metabolite associated with wakefulness-promoting compounds, with reported potency well below that of modafinil. However, it is important to be clear that these properties belong to fluorenol, not to fluorene myristate specifically, and no published pharmacology, pharmacokinetics or toxicology exists for the myristate ester under its own name. Supplier listings even disagree on its molecular formula and CAS number, which further undermines confidence in any precise claims.

Given the absence of primary studies, fluorene myristate should be treated as an unverified experimental substance. Any expectation that it behaves like a mild dopaminergic wakefulness agent is an inference from its presumed parent compound, not an established fact.

Honestly, the safety profile of fluorene myristate is unknown, because no toxicology or human data exist for it. Even its parent fluorenol (hydrafinil) has essentially no formal safety testing and is widely flagged as a dopaminergic stimulant of questionable safety. That means side effects, interactions, cardiovascular risk and long-term consequences are all unstudied. It is strictly a research chemical, not an approved supplement or drug, and there is no basis for considering it safe for human consumption. Anyone handling it should treat it as an unknown experimental substance.

There is no documented discovery or development history for fluorene myristate in the scientific literature; it has appeared only as a vendor-sold research chemical. Its conceptual lineage traces to fluorene and 9-fluorenol chemistry, with fluorenol (hydrafinil) having been popularized as a modafinil-related eugeroic in the nootropic market rather than through formal pharmaceutical development.

Fluorene myristate is a fringe, poorly understood compound with negligible reputation even within nootropic circles; it is occasionally discussed as an experimental fatty-acid ester of hydrafinil but lacks the user base, reviews or research backing of established stimulants. The honest assessment is that it is speculative, undocumented, and its purported benefits rest on extrapolation from fluorenol rather than any evidence for the ester itself.